Montelukast 10mg Tablet (VA-25-00102867)   3

Background
The Department of Veterans Affairs (VA) is seeking to establish a contract for the supply of Montelukast 10mg Tablets as part of its pharmaceutical requirements through the VA Pharmaceutical Prime Vendor (PPV) Program. The goal of this contract is to ensure availability and consistency of pharmaceutical products for nationwide usage while obtaining volume-based, committed-use pricing.

This solicitation aims to provide a reliable source for drugs listed in the schedule for purchase through the PPV Programs, which also includes participants from the Department of Defense (DoD), Indian Health Service (IHS), and Bureau of Prisons (BOP).

Work Details
The contract involves supplying Montelukast 10mg Tablets with specific requirements for packaging and labeling. The tablets must be delivered in unit-of-use packaging that includes safety caps and bottles with a minimum size requirement. The details are as follows:
- **Montelukast 10mg Tablet**
- **Quantity**: 8,378 bottles per year for the base year and each option year.
- **Packaging**: Each bottle must contain 30 tablets and have a cylindrical body with a minimum circumference of 5.75 inches. The label must fit dimensions of 5.25 inches by 2 inches, allowing space for barcodes, expiration dates, and lot numbers.
- **Cost Recovery Fee**: A fee of 0.5% must be included in the offered prices.
- **NDC Requirement**: Offerors must provide an 11-digit National Drug Code (NDC) number unique to their company for each drug offered.

Period of Performance
The contract will be effective upon signing and will include a base year with four one-year options.

Place of Performance
Products will be delivered to multiple VA distribution centers across the United States as specified by the Government Prime Vendor contractors.